PLK1 and neoplasm: Moreover, the strategies that integrate PLK1 blockade and tumor-killers or immunomodulators, which promote the antitumor cytotoxicity and awaken immunity against immunosuppressive TME, might be a promising approach for maximizing the effect of PLK1 blockade in future.